文献速递中毒与环境急症消化、代谢与肾脏急症

对乙酰氨基酚与转氨酶乘积在对乙酰氨基酚中毒后风险分层中的表现:系统评价与荟萃分析

Performance of the paracetamol-aminotransferase multiplication product in risk stratification after paracetamol (acetaminophen) poisoning: a systematic review and meta-analysis.
PubMed 文献 · Clin Toxicol (Phila) · 2022-11-29
一句话结论对乙酰氨基酚×转氨酶乘积可预测对乙酰氨基酚中毒后的肝毒性,弥补Rumack-Matthew列线图在超过24小时就诊及多次摄入场景的不足。

该系统评价与荟萃分析纳入6项研究共5036例对乙酰氨基酚中毒患者,评估对乙酰氨基酚浓度×转氨酶乘积对肝毒性的诊断性能。使用1500 mg/L×IU/L界值时,诊断比值比31.90(95%CI: 9.52-106.90),敏感性0.98(95%CI: 0.94-1.00),特异性0.66(95%CI: 0.49-0.89);使用10,000 mg/L×IU/L界值时,诊断比值比99.34(95%CI: 12.26-804.87),敏感性0.65(95%CI: 0.51-0.82),特异性0.97(95%CI: 0.95-1.00)。在多次摄入患者中,1500 mg/L×IU/L界值诊断比值比69.53(95%CI: 4.03-1199.75),敏感性1.00(95%CI: 0.87-1.00),特异性0.74(95%CI: 0.43-1.00);10,000 mg/L×IU/L界值诊断比值比254.58(95%CI: 11.12-5827.60),敏感性0.79(95%CI: 0.59-1.00),特异性0.98(95%CI: 0.94-1.00)。总体汇总受试者工作特征曲线下面积0.91(95%CI: 0.75-0.97),最佳界值3840 mg/L×IU/L;多次摄入患者曲线下面积0.96(95%CI: 0.85-0.99);多次摄入且就诊时对乙酰氨基酚浓度低于检测限10 mg/

要点

  • 1500 mg/L×IU/L界值敏感性高(0.98,95%CI: 0.94-1.00),适用于排除肝毒性风险。
  • 10,000 mg/L×IU/L界值特异性高(0.97,95%CI: 0.95-1.00),适用于确认肝毒性风险。
  • 多次摄入患者中,1500 mg/L×IU/L界值敏感性1.00(95%CI: 0.87-1.00),10,000 mg/L×IU/L界值诊断比值比254.58(95%CI: 11.12-5827.60)。
  • 总体最佳界值为3840 mg/L×IU/L,汇总受试者工作特征曲线下面积0.91(95%CI: 0.75-0.97)。
  • 该乘积可在中毒超过24小时后及多次摄入场景中使用,弥补Rumack-Matthew列线图的局限。

适用人群与场景

  • 对乙酰氨基酚(扑热息痛)中毒患者,包括单次摄入和多次摄入者。

诊断标准与关键阈值

  • 评估两个常用界值:对乙酰氨基酚浓度×转氨酶乘积1500 mg/L×IU/L和10,000 mg/L×IU/L。
  • 总体最佳界值为3840 mg/L×IU/L。
  • 就诊时对乙酰氨基酚浓度低于检测限10 mg/L可用于多次摄入患者的场景分析。

研究设计与关键结果

  • 系统评价与荟萃分析纳入6项研究,共5036例参与者。
  • 在4051例患者中,1500 mg/L×IU/L界值的诊断比值比31.90(95%CI: 9.52-106.90),敏感性0.98(95%CI: 0.94-1.00),特异性0.66(95%CI: 0.49-0.89)。
  • 在3983例患者中,10,000 mg/L×IU/L界值的诊断比值比99.34(95%CI: 12.26-804.87),敏感性0.65(95%CI: 0.51-0.82),特异性0.97(95%CI: 0.95-1.00)。
  • 多次摄入患者中,1500 mg/L×IU/L界值的诊断比值比69.53(95%CI: 4.03-1199.75),敏感性1.00(95%CI: 0.87-1.00),特异性0.74(95%CI: 0.43-1.00)。
  • 多次摄入患者中,10,000 mg/L×IU/L界值的诊断比值比254.58(95%CI: 11.12-5827.60),敏感性0.79(95%CI: 0.59-1.00),特异性0.98(95%CI: 0.94-1.00)。
  • 总体汇总受试者工作特征曲线下面积0.91(95%CI: 0.75-0.97)。
  • 多次摄入患者汇总受试者工作特征曲线下面积0.96(95%CI: 0.85-0.99);多次摄入且就诊时对乙酰氨基酚浓度低于检测限10 mg/L的患者曲线下面积0.97(95%CI: 0.94-0.99)。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入6项研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为对乙酰氨基酚×转氨酶乘积可用于预测对乙酰氨基酚中毒患者的肝毒性。
  • 作者认为该乘积可补充Rumack-Matthew列线图,因其在中毒与乙酰半胱氨酸治疗间隔超过24小时以及多次摄入的场景中显示出应用前景。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Risk stratification in paracetamol (acetaminophen) poisoning is crucial because hepatotoxicity is common and can be mitigated with treatment. However, current risk stratification tools have limitations.

AIMS: We evaluated the diagnostic performance of the paracetamol concentration × aminotransferase multiplication product, for predicting hepatotoxicity after paracetamol overdose.

METHODS: Medline, Cochrane Library and Embase were searched for eligible papers. We used random effects models to obtain pooled estimates of the likelihood ratios and diagnostic odds ratios, from which sensitivity and specificity were computed. We assessed two commonly used cut-off values of paracetamol × aminotransferase, 1500 mg/L × IU/L and 10,000 mg/L × IU/L. Using the confusion matrices of these two cut-offs, area under the summary receiver operator characteristic curve and optimal cut-off values in different clinical scenarios were established.

RESULTS: Six studies comprising 5036 participants were included. In 4051 patients, using the cut-off of 1500 mg/L × IU/L, a diagnostic odds ratio of 31.90 (95%CI: 9.52-106.90), sensitivity of 0.98 (95%CI: 0.94-1.00) and specificity of 0.66 (95%CI: 0.49-0.89) were obtained. In 3983 patients, using the cut-off of 10,000 mg/L × IU/L, a diagnostic odds ratio of 99.34 (95%CI: 12.26-804.87), sensitivity of 0.65 (95%CI: 0.51-0.82) and specificity of 0.97 (95%CI: 0.95-1.00) were obtained. For staggered ingestions, the 1500 mg/L × IU/L cut-off yielded a diagnostic odds ratio of 69.53 (95%CI: 4.03-1199.75), sensitivity of 1.00 (95%CI: 0.87-1.00) and specificity of 0.74 (95%CI: 0.43-1.00). Next, using the 10,000 mg/L × IU/L cut-off in this scenario yielded a diagnostic odds ratio of 254.58 (95%CI: 11.12-5827.60), sensitivity of 0.79 (95%CI: 0.59-1.00) and specificity of 0.98 (95%CI: 0.94-1.00). The overall summary receiver operator characteristic curve was 0.91 (95%CI: 0.75-0.97), and the optimal cut-off value was 3840 mg/L × IU/L. The summary receiver operator characteristic curve in patients with staggered ingestions was 0.96 (95%CI: 0.85-0.99). The summary receiver operator characteristic curve in patients with staggered ingestions and whose paracetamol concentration was below the detectable limit of 10 mg/L at presentation was 0.97 (95%CI: 0.94-0.99).

CONCLUSION: In this first meta-analysis, paracetamol × aminotransferase demonstrates its use in prognosticating hepatotoxicity in patients with paracetamol poisoning. It complements the Rumack-Matthew nomogram as it has shown promise in addressing two key limitations of the nomogram: it is usable after more than 24 h between overdose and acetylcysteine treatment, and it is applicable in staggered ingestions.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Yau CE, Chen H, Lim BP, et al. Performance of the paracetamol-aminotransferase multiplication product in risk stratification after paracetamol (acetaminophen) poisoning: a systematic review and meta-analysis. Clin Toxicol (Phila). 2022. PMID: 36444937. doi:10.1080/15563650.2022.2152350

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。